Pharmacotherapeutic approaches in the treatment of Alzheimer ’ s Disease

@inproceedings{BPharm2006PharmacotherapeuticAI,
  title={Pharmacotherapeutic approaches in the treatment of Alzheimer ’ s Disease},
  author={Charles Scerri BPharm},
  year={2006}
}
  • Charles Scerri BPharm
  • Published 2006
Alzheimer’s disease (AD) is the most common form of dementia and accounts for major cognitive impairment in the elderly. It is a progressive neurodegenerative disorder with distinct pathology. At present, the pharmacotherapy of AD involves the use of acetylcholinesterase inhibitors and the N-methyl-D-aspartate (NMDA) receptor antagonist memantine. The former imply neuroprotection hence slowing disease progression while the latter may block neuronal excitotoxicity. Charles Scerri BPharm (Hons… CONTINUE READING